Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array
Over one million prostate biopsies are performed in the U.S. every year. However, pathology examination is not definitive in a significant percentage of cases due limited diagnostic tumor. We have observed that the microenvironment of prostate tumor cells exhibits numerous differential gene expression changes and have asked whether such information can be used to distinguish “tumor” from “nontumor”. We initially compared expression analysis data (Affymetrix U133plus2) from 18 volunteer biopsy sp...
Provenance — who produced it, who reused it
Linked to 28 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- Conservation of immune gene signatures in solid tumors and progn... 2016 · 126 cites
- Weighted Frequent Gene Co-expression Network Mining to Identify... 2012 · 86 cites
- Molecular Profiling of Multiple Human Cancers Defines an Inflamm... 2013 · 86 cites
- PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 s... 2018 · 83 cites
- Epithelial tumor suppressor ELF3 is a lineage-specific amplified... 2019 · 71 cites
23 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently